Analyst firms · Evercore ISI · BLCO

Evercore ISI BLCO price target and rating history

Bausch + Lomb Corporation (BLCO) · Health Care

Evercore ISI rates Bausch + Lomb Corporation (BLCO) In-line with a $18 price target, as of its latest action on Jan 5, 2026. It has published 4 rating actions on BLCO since October 2023, including 1 upgrade and 2 downgrades. Across 7 firms with a BLCO price target in the last 12 months, the median target is $21. Evercore ISI's $18 is 14% below that.

Current rating
In-line
Price target
$18
Median target, all firms
$21
Actions on BLCO
4

Evercore ISI price target on BLCO

$25$21$17202420252026
Evercore ISI price target on BLCO, each point a stated target, October 2023 to January 2026.

Every Evercore ISI rating on BLCO

How other firms rate BLCO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightNeutral$22Nov 2, 2026
BarclaysOverweight$24Oct 7, 2026
Leerink PartnersOutperform$24Sep 9, 2026
UBSBuy$21Jul 28, 2026
Evercore ISIIn-line$18Jan 5, 2026
CitigroupBuy$20Dec 11, 2025
Morgan StanleyOverweight$21Dec 2, 2025

Questions about Evercore ISI and BLCO

What is Evercore ISI's price target for BLCO?
Evercore ISI's latest stated price target for Bausch + Lomb Corporation (BLCO) is $18, from its action on Jan 5, 2026.
What is Evercore ISI's rating on BLCO?
Evercore ISI rates BLCO In-line, a neutral rating, as of Jan 5, 2026.
When did Evercore ISI last change its view on BLCO?
On Jan 5, 2026, Evercore ISI downgrades to In-line from Outperform, price target $18.
How does Evercore ISI's BLCO target compare with other analysts?
Across 7 firms with a BLCO price target in the last 12 months, the median target is $21. Evercore ISI's $18 is 14% below that.

More BLCO rating histories

All Evercore ISI ratingsBLCO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.